These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 10845829)

  • 1. Physiological confounders of renal blood flow measurement.
    Alhummiany B; Sharma K; Buckley DL; Soe KK; Sourbron SP
    MAGMA; 2024 Aug; 37(4):565-582. PubMed ID: 37971557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Normalizing eGFR to Standard Body Surface Area on Rates of Obesity-Related Hyperfiltration among Diverse Female Adolescents.
    Bielopolski D; Bentur OS; Singh N; Vaughan RD; Charytan DM; Kost RG; Tobin JN
    Am J Nephrol; 2022; 53(4):282-289. PubMed ID: 35378531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modern pharmacological treatment of obese patients.
    May M; Schindler C; Engeli S
    Ther Adv Endocrinol Metab; 2020; 11():2042018819897527. PubMed ID: 32030121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Medication Dosing in the Obese Patient.
    Erstad BL
    Clin Drug Investig; 2017 Jan; 37(1):1-6. PubMed ID: 27599484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.
    D'Agati VD; Chagnac A; de Vries AP; Levi M; Porrini E; Herman-Edelstein M; Praga M
    Nat Rev Nephrol; 2016 Aug; 12(8):453-71. PubMed ID: 27263398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of glomerular filtration rate in obese children.
    Correia-Costa L; Schaefer F; Afonso AC; Bustorff M; Guimarães JT; Guerra A; Barros H; Azevedo A
    Pediatr Nephrol; 2016 Aug; 31(8):1321-8. PubMed ID: 27008644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between obesity and glomerular hyperfiltration: the confounding effect of smoking and sodium and protein intakes.
    Ogna A; Forni Ogna V; Bochud M; Guessous I; Paccaud F; Burnier M; Wuerzner G
    Eur J Nutr; 2016 Apr; 55(3):1089-97. PubMed ID: 25971845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing drug regimens for special intensive care unit populations.
    Erstad BL
    World J Crit Care Med; 2015 May; 4(2):139-51. PubMed ID: 25938029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indexing glomerular filtration rate to body surface area: clinical consequences.
    Redal-Baigorri B; Rasmussen K; Heaf JG
    J Clin Lab Anal; 2014 Mar; 28(2):83-90. PubMed ID: 24375613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
    Ghobadi C; Johnson TN; Aarabi M; Almond LM; Allabi AC; Rowland-Yeo K; Jamei M; Rostami-Hodjegan A
    Clin Pharmacokinet; 2011 Dec; 50(12):809-22. PubMed ID: 22087867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of glomerular filtration rate in obese patients: pitfalls and potential consequences on drug therapy.
    Wuerzner G; Bochud M; Giusti V; Burnier M
    Obes Facts; 2011; 4(3):238-43. PubMed ID: 21701241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lean body mass normalizes the effect of obesity on renal function.
    Janmahasatian S; Duffull SB; Chagnac A; Kirkpatrick CM; Green B
    Br J Clin Pharmacol; 2008 Jun; 65(6):964-5. PubMed ID: 18279477
    [No Abstract]   [Full Text] [Related]  

  • 13. Dosing strategy for enoxaparin in patients with renal impairment presenting with acute coronary syndromes.
    Green B; Greenwood M; Saltissi D; Westhuyzen J; Kluver L; Rowell J; Atherton J
    Br J Clin Pharmacol; 2005 Mar; 59(3):281-90. PubMed ID: 15752373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A standard weight descriptor for dose adjustment in the obese patient.
    Duffull SB; Dooley MJ; Green B; Poole SG; Kirkpatrick CM
    Clin Pharmacokinet; 2004; 43(15):1167-78. PubMed ID: 15568893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the best size descriptor to use for pharmacokinetic studies in the obese?
    Green B; Duffull SB
    Br J Clin Pharmacol; 2004 Aug; 58(2):119-33. PubMed ID: 15255794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular filtration rate in severely overweight normotensive humans.
    Anastasio P; Spitali L; Frangiosa A; Molino D; Stellato D; Cirillo E; Pollastro RM; Capodicasa L; Sepe J; Federico P; Gaspare De Santo N
    Am J Kidney Dis; 2000 Jun; 35(6):1144-8. PubMed ID: 10845829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population.
    Wuerzner G; Pruijm M; Maillard M; Bovet P; Renaud C; Burnier M; Bochud M
    Am J Kidney Dis; 2010 Aug; 56(2):303-12. PubMed ID: 20538392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of glomerular filtration rate, renal plasma flow, and endogenous creatinine clearance in cheetahs (Acinonyx jubatus jubatus).
    Holder EH; Citino SB; Businga N; Cartier L; Brown SA
    J Zoo Wildl Med; 2004 Jun; 35(2):175-8. PubMed ID: 15305512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men.
    Chew-Harris JS; Florkowski CM; George PM; Elmslie JL; Endre ZH
    Ann Clin Biochem; 2013 Jan; 50(Pt 1):39-46. PubMed ID: 23129724
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.